Member Info for daringinvestor

should show more efficacy?

Why is the higher dose was less effective?

Just a chance result?

The small sample size does not help and does not bode well for phase 3 if they go down that route, which the FDA will demand has a much larger sample size.

Looking at Verona Pharma today and their phase 2 results... I cannot emphasise enough the significance of our phase 2 study.
Thankfully our phase 2 was a success and the higher doses will show increased efficacy on the other group of patients (more severe cases of ED)
Granted things have not been handled great but the product looks like a good one.

Got you hawkhead
Thanks for the clarification

Looks like your calculation was way out hawkhead
Or have I read the RNS wrong??

Anyone?

What a sensible post.
At last.

Doubt it Jet7.

More likely probably down to the RNS and the publication of the article in the magazine..

absolutely agree

No predictions from me.... It's a long road ahead

The recent increase in share price seems to be with the company being covered by the Growth Company Investor

https://www.growthcompany.co.uk/

Check RNS on FUM website

Rhodi - You are correct.

I don't think anyone can sit here and say "if" this happened and "if" that happened we would be worth billions... It's wishful thinking..

Do I think the share price will rise as we get closer to the results assuming no significant bad news on clinical trials - Yes
Do I think if phase 3 trials are a success the share price will rise above the 25p or 35p valuation given on this forum - Yes
Will it get to the dizzy heights of £4.56 - No

Will we be significantly higher than the current share price of 10p if things go well for phase 3 - Yes

GLA

Rhodi - no one on this board knows what the share price will be or indeed whether phase 3 trials are a success.

Looking at some of your historical posts, you seemed to be extremely bullish. In fact bullish than most. You have now swung from that extreme bullishness to the bearish of them all.

The one thing all of us have in common is we are all FUM investors. I hope we all salvage something from FUM.

Good luck all.

To be honest I can’t see this being outlicensed.

It’ll just be sold.

We all know how the existing licensing deals have gone, sometimes for reasons out of the companies control and sometimes due to the naivety/ cock ups of the management

I can’t see the share price reaching the values quoted £4.56

Yes if it does good in phase 3, I’d see a buyout price of around £1.50 or £2 if we’re lucky.

Anyone else notice that the patients will be mild, moderate or severe ED patients.... not Moderate AND severe...

I think it'll be Mild, Mild to moderate and moderate,

I think the severe patients will not be included judging by the above

I see some talk about the company diluting whenever they need to fill a large order.

As the company moves to profitability (and they are getting there), this is / will become less of a problem
First step is to get profitability
Once profits roll in, boost the cash balance of the company to fill the large orders

Yes we are not there yet, but we sure as hell are getting there.
As we approach that point the share price will rise
Meaning less dilution to raise the same funds

We are heading in the right direction and that’s what counts

Rhodi
Enrolled = receiving medication

Once enrolled they get given the tubes of med2002
It is then down to them to use this as and when required.
Futura Medical will not “dose” for obvious reasons.
Ken is not going to stand in someone’s bedroom dosing them before the action starts

Futura Medical does not dose the patients.

The men use the gel in the comfort of their own homes. Therefore Futura Medical has to use the word “enrolled” and NOT dose as some are expecting.

Once enrolled each patient is given a number of doses and asked to use them by an end date.

Rhodi
I absolutely agree with you in a lot of respects and you are fully entitled to feel agrieved as are all of us.

All I’m saying is do you not feel that you should make an effort and give them a piece of your mind. I think you should go and unleash the fury so to speak.

So Rhodi, you would not even waste petrol money to go to the meeting yet type away as a keyboard warrior on this message board cursing the management and coming out with what you would have done.

If you feel so strongly about all that has happened which is evident from your posts, Why don’t you make the effort in attending the meeting and challenge the management and ask them the straight up questions you shout out about on here?

At least that would be more constructive then just shouting out ideas on this board

I think if there’s one person that understands the product it’s Ken James. As we all know he has bought in at the latest share issue. Approx £20k

The factors will be used for commercial claims and MED showed statistical significance for all the above points.
One thing to note is Viagra did not use any claims for “increased sexual desire” as they were advised against doing so due to potential litigations , ie. People blaming Viagra for committing sexual crimes as it could easily be spiked into a drink without one noticing and therefore they did not wish to use the claim of “increased sexual desire”
With MED I don’t see this as being a problem. The phase 2 showed statistical significance for this category of increasing sexual desire. I don’t think it’s a problem for med for making this claim because let’s face it, no one can accuse of someone else of forcefully grabbing their penis and proceeding to rub MED gel without their knowledge… and provided it continues to show the statistical evidence in phase 3, one claim which could be made (backed by the statistical evidence) is for it to increase sexual desire.
The specific questions in the IIEF questionnaire for sexual desire are worded as follows
“The next two questions ask about sexual desire. In this context, sexual desire is defined as a feeling that may include wanting to have a sexual experience (for example masturbation or sexual intercourse), thinking about having sex, or feeling frustrated due to lack of sex.
Q11. Over the last month, how often have you felt sexual desire?
5 being almost always and 1 being almost never
Q12. Over the last month, how would you rate your level of sexual desire?
5 being very high and 1 being very low

So, hopefully we show increased statistical evidence with increased doses and continue to show statistical evidence for the sexual desire question.

That post took ages so hopefully some of the fellow investors find it useful!!